rhinitis%20-%20allergic
RHINITIS - ALLERGIC
Allergic rhinitis is a symptomatic disorder of the nose secondary to IgE-mediated inflammation of the nasal membranes induced after exposure to allergens.
Major symptoms include nasal itching, watery rhinorrhea, nasal obstruction/congestion, sneezing and postnasal drainage.
Other symptoms include headache, conjunctival symptoms, eye pruritus, impaired smell and morning cough.
Symptoms can reverse spontaneous w/ or w/o treatment.

Definition

Rhinitis

  • Inflammation of the nasal lining membranes

 Allergic Rhinitis

  • A symptomatic disorder of the nose secondary to IgE-mediated inflammation of the nasal membranes induced after exposure to allergens

Signs and Symptoms

Major symptoms

  • Nasal itching
  • Watery rhinorrhea
  • Nasal obstruction/congestion
  • Sneezing
  • Postnasal drainage

Other symptoms

  • Headache
  • Conjunctival symptoms, eye pruritus
  • Impaired smell
  • Morning cough

Symptoms can reverse spontaneously with or without treatment

Pathophysiology

  • There may be various diatheses for allergic rhinitis sensitization but the most important mechanisms are:
    • Genetic factors 
    • Production of IgE antibody 
  • Most allergic rhinitis are caused by inhalation antigens such as:
    • Dermatophagoides (antigen in house dust) - most common
    • Pollens (eg trees, grasses and weeds) - most common
    • Fungi
    • Pets
  • Two phase reactions:
    • Early phase reaction happens when histamine and leukotrienes are released from mast cells and irritates the sensory nerve endings and blood vessels of the nasal mucosa
      • This irritation causes sneezing, rhinorrhea (watery), nasal mucosal swelling or blockage 
    • Late phase reaction happens when inflammatory cells like activated eosinophils infiltrate the nasal mucosa that are exposed to these antigens
      • Seen 6-10 hours after the exposure to antigens
      • Causes mucosal swelling
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 25 Oct 2016

Nivolumab did not meet the primary endpoint of superior progression-free survival (PFS) vs platinum-based chemotherapy in the phase III Checkmate026 trial in patients with stage IV recurrent, PD-L1–positive non-small-cell lung carcinoma (NSCLC), according to results reported recently at the European Society of Medical Oncology (ESMO) Congress 2016. 

Pearl Toh, 24 Nov 2016
New treatments such as pirfenidone and nintedanib slow lung function decline and progression of idiopathic pulmonary fibrosis (IPF), although response to treatment can vary dramatically among patients, according to a presentation at the 21st Congress of the Asian Pacific Society of Respirology (APSR 2016) held in Bangkok, Thailand.
16 Oct 2016
Irritable bowel syndrome and asthma share a bidirectional association, a new study reports. Further, atopy potentially plays a role in the underlying mechanisms of this association.
Audrey Abella, 09 May 2018
The potent and highly selective RET* inhibitor BLU-667 was well-tolerated and exhibited promising clinical activity among patients with advanced, RET-altered solid cancers that progressed despite multikinase inhibitor therapy, according to data presented at AACR 2018.